- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles
- Related Articles1 new
- Instablogs
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
IDIX Market Currents
more »
-
April 30 Idenix Pharmaceuticals (IDIX +6.5%) jumps on an upgrade to Market Perform on valuation at JMP Securities, citing its emerging pipeline.
Comment![Healthcare, On the Move]
IDIX in Focus
more »
IDIX Related Articles
more »
IDIX News
more »
-
at CNBC.com (Fri, 6:01AM)
-
at CNBC.com (Thu, 6:48PM)
-
at MarketWatch.com (Apr 19, 2012)
-
at MarketWatch.com (Feb 14, 2012)
-
at MarketWatch.com (Feb 3, 2012)
IDIX Press Releases and Filings
more »
-
GlobeNewswire (May 2, 2012)
-
GlobeNewswire (Apr 30, 2012)
-
GlobeNewswire (Apr 19, 2012)
-
PR Newswire (Jan 9, 2012)
-
PR Newswire (Jan 9, 2012)
IDIX Latest Transcript
more »
IDIX Cramer
more »
Currently, there are no Cramer articles on IDIX.
IDIX Instablog posts
more »
IDIX vs. ETF Alternatives
Company Description
Currently, there's no company description for IDIX.
